- Home
- AIRS vs ZYXI Comparison
AIRS vs ZYXI Comparison
Compare AIRS & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- ZYXI
- Stock Information
- Founded
- AIRS 2012
- ZYXI 1996
- Country
- AIRS United States
- ZYXI United States
- Employees
- AIRS N/A
- ZYXI N/A
- Industry
- AIRS Medical/Nursing Services
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIRS Health Care
- ZYXI Health Care
- Exchange
- AIRS Nasdaq
- ZYXI Nasdaq
- Market Cap
- AIRS 249.9M
- ZYXI 257.1M
- IPO Year
- AIRS 2021
- ZYXI N/A
- Fundamental
- Price
- AIRS $4.79
- ZYXI $7.83
- Analyst Decision
- AIRS Hold
- ZYXI Strong Buy
- Analyst Count
- AIRS 2
- ZYXI 2
- Target Price
- AIRS $5.50
- ZYXI $14.00
- AVG Volume (30 Days)
- AIRS 108.2K
- ZYXI 93.0K
- Earning Date
- AIRS 11-07-2024
- ZYXI 10-24-2024
- Dividend Yield
- AIRS N/A
- ZYXI N/A
- EPS Growth
- AIRS N/A
- ZYXI N/A
- EPS
- AIRS N/A
- ZYXI 0.18
- Revenue
- AIRS $193,025,000.00
- ZYXI $193,614,000.00
- Revenue This Year
- AIRS N/A
- ZYXI $11.68
- Revenue Next Year
- AIRS $11.85
- ZYXI $20.90
- P/E Ratio
- AIRS N/A
- ZYXI $43.05
- Revenue Growth
- AIRS 6.58
- ZYXI 9.11
- 52 Week Low
- AIRS $2.92
- ZYXI $7.04
- 52 Week High
- AIRS $8.30
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- AIRS 51.97
- ZYXI 44.68
- Support Level
- AIRS $4.36
- ZYXI $7.71
- Resistance Level
- AIRS $5.95
- ZYXI $8.45
- Average True Range (ATR)
- AIRS 0.52
- ZYXI 0.33
- MACD
- AIRS -0.01
- ZYXI -0.01
- Stochastic Oscillator
- AIRS 40.33
- ZYXI 14.68
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.